Percutaneous transluminal coronary angioplasty in silent ischemia
E M Tuzcu1, Y Nisanci, C Simpfendorfer
1Department of Cardiology, Cleveland Clinic Foundation, OH 44195.
Insights
Percutaneous transluminal coronary angioplasty (PTCA) shows promise for treating asymptomatic coronary artery disease. This procedure demonstrated high success rates and favorable long-term outcomes in a patient cohort.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Clinical Outcomes Research
Background:
- Silent ischemia, indicated by coronary artery disease without symptoms, presents a challenge in treatment selection.
- Abnormal stress tests frequently identify significant coronary artery disease in asymptomatic individuals.
Purpose of the Study:
- To evaluate the short- and long-term outcomes of percutaneous transluminal coronary angioplasty (PTCA) in patients with asymptomatic coronary artery disease.
- To assess the efficacy and safety of PTCA as a therapeutic option for silent ischemia.
Main Methods:
- Analysis of 34 patients with documented coronary artery disease and no symptoms.
- Pre- and post-angioplasty stress tests and follow-up catheterization were utilized.
- 100% patient follow-up for a mean of 36 months, assessing cardiac survival and freedom from adverse events.
Main Results:
- PTCA success rate was 91% (31 out of 34 patients).
- 29 out of 31 successfully treated patients showed normal or improved exercise test results post-procedure.
- Actuarial cardiac survival at 3 years was 100%, with 87% freedom from major adverse cardiac events.
Conclusions:
- Percutaneous transluminal coronary angioplasty appears to be a viable therapeutic option for selected patients with asymptomatic coronary artery disease.
- Further research is needed to establish the optimal treatment strategy for silent ischemia.
Abstract:
The short- and long-term outcome of percutaneous transluminal coronary angioplasty were analyzed in 34 patients who had documented coronary artery disease without symptoms. Of the 34 patients, 33 had abnormal stress tests before angioplasty. Angioplasty was successful in 31 patients (91%). Follow-up was 100% for a mean period of 36 +/- 15 months. Follow-up exercise test was normal or improved in 29 of the 31 patients who had successful angioplasty. Follow-up catheterization was performed in 24 of the 31 patients (77%). Restenosis of the previously dilated segment was found in seven patients. Actuarial cardiac survival at 3 years was 100%. Freedom from myocardial infarction, bypass surgery, angioplasty for a new lesion, and death was 87%. We conclude that although the most effective treatment for silent ischemia remains to be determined, our data suggest that coronary angioplasty is a therapeutic option in these patients.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Peripheral Artery Disease III: Interprofessional Care
Transient Ischemic Attack l: Introduction
